In This Article:
Kits Eyecare (TSE:KITS) Second Quarter 2024 Results
Key Financial Results
-
Revenue: CA$37.9m (up 26% from 2Q 2023).
-
Net income: CA$187.0k (up from CA$1.18m loss in 2Q 2023).
-
Profit margin: 0.5% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue.
-
EPS: CA$0.006 (up from CA$0.038 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Kits Eyecare Earnings Insights
Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Specialty Retail industry in Canada.
Performance of the Canadian Specialty Retail industry.
The company's shares are down 3.1% from a week ago.
Balance Sheet Analysis
While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Kits Eyecare's balance sheet.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.